Brewster Marcus E, Loftsson Thorsteinn
Chemical and Pharmaceutical Development, Johnson & Johnson Pharmaceutical Research and Development, Janssen Pharmaceutica, Turnhoutseweg 30, B-2340 Beerse, Belgium.
Adv Drug Deliv Rev. 2007 Jul 30;59(7):645-66. doi: 10.1016/j.addr.2007.05.012. Epub 2007 May 29.
Cyclodextrins are useful functional excipients that have enjoyed widespread attention and use. The basis for this popularity from a pharmaceutical standpoint, is the ability of these materials to interact with poorly water-soluble drugs and drug candidates resulting in an increase in their apparent water solubility. The mechanism for this solubilization is rooted in the ability of cyclodextrin to form non-covalent dynamic inclusion complexes in solution. Other solubilizing attribute may include the ability to form non-inclusion based complexes, the formation of aggregates and related domains and the ability of cyclodextrins to form and stabilize supersaturated drug solutions. The increase in solubility also can increase dissolution rate and thus improve the oral bioavailability of BCS Class II and IV materials. A number of cyclodextrin-based products have reached the market based on their ability to camouflage undesirable physicochemical properties. This review is intended to give a general background to the use of cyclodextrin as solubilizers as well as highlight kinetic and thermodynamic tools and parameters useful in the study of drug solubilization by cyclodextrins.
环糊精是有用的功能性辅料,已受到广泛关注并得到应用。从药学角度来看,其受欢迎的原因在于这些材料能够与难溶性药物及候选药物相互作用,从而提高它们的表观水溶性。这种增溶作用的机制源于环糊精在溶液中形成非共价动态包合物的能力。其他增溶特性可能包括形成非包合型复合物的能力、聚集体和相关区域的形成,以及环糊精形成和稳定过饱和药物溶液的能力。溶解度的提高还可以加快溶解速率,从而改善BCS II类和IV类物质的口服生物利用度。许多基于环糊精的产品已投放市场,因为它们能够掩盖不良的物理化学性质。本综述旨在提供使用环糊精作为增溶剂的一般背景知识,并突出在研究环糊精增溶药物方面有用的动力学和热力学工具及参数。